Trials / Completed
CompletedNCT05725122
Stone Clearance in Patients With Upper Ureteric Stones Using Extracorporeal Shock Wave Lithotripsy Compared With Extracorporeal Shock Wave Lithotripsy Combined With Tamsulosin Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Services Hospital, Lahore · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Extracorporeal shock wave lithotripsy (ESWL) is the least invasive and effective treatment for upper ureteric stones with a stone clearance rate of 60-90%. Tamsulosin is an alpha-blocker widely used in urological practice to relax smooth muscle of the prostate and bladder neck. Its role as part of medical expulsion therapy for the treatment of patients with kidney and ureteric stones has proved to be of considerable success. However, its role in clearing upper ureteric stones as an adjunct to ESWL is controversial. Therefore, this study will be conducted to evaluate its role in stone clearance along with extracorporeal shock wave lithotripsy in patients with upper ureteric stones
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Extracorporeal shock wave lithotripsy | Extracorporeal shock wave lithotripsy will given to the patients |
| PROCEDURE | Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy. | Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy will be given to the patients |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2023-02-13
- Last updated
- 2023-02-13
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05725122. Inclusion in this directory is not an endorsement.